New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 25, 2014
08:20 EDTDANOYDanone reports Q2 like-for-like sales up 2.3% to EUR5.41B
Danone reports Q2 consolidated sales declined 5.5% to total EUR5.406B. Excluding the impact of changes in the basis for comparison, which include exchange rates and scope of consolidation, sales were up 2.3%. This organic growth reflects a 3.9% decrease in sales volume and a 6.2% rise in value. First half underlying fully diluted EPS totaled EUR1.16, down 11.1% like-for-like from the first half of 2013. The company said, “The first half of the year was particularly eventful, and had all of our teams 100% mobilized. First, we responded to record milk prices with key initiatives in various fields —pricing, mix, cost-cutting measures—, all designed to rebuild margins that had come under serious pressure in the first quarter. And these efforts paid off."
News For DANOY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 12, 2014
06:44 EDTDANOYDanone backs 2014 organic growth target of 4.5%
Backs 2014 trading operating margin down less than 20 basis points like-for-like. Backs 2014 free cash flow to be between EUR1.3B-EUR1.4B. Danone said it will continue to expand capacity rapidly and build development platforms in fast-growing regions, particularly Asia and Africa. Investments made for this purpose over the past two years have resulted in a higher use of debt than in the past, at a level that could imply a credit rating one notch lower, and that is appropriate for this current period of development given the company’s sound cash-flow outlook and debt structure.
06:42 EDTDANOYDanone to keep Medical Nutrition business, Reuters reports
Subscribe for More Information
December 11, 2014
07:13 EDTDANOYDanone to discuss whether to keep or sell medical nutrition unit, Reuters says
According to a source, Danone (DANOY) will hold a board meeting today to discuss whether to keep or sell its medical nutrition business, Reuters reports. Previous reports said Danone's board would decide whether to sell the unit to Hospira (HSP) or Fresenius (FMS), with Fresenius as the possible front-runner to enter exclusive talks. Reference Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use